TheraSkin pharmaceutical in mira

National pharmaceutical TheraSkin, controlled by family Scaravelli, became the target of other groups for a possible acquisition, the State found.
With revenues of R$ in 2015, the company''s 200,000,000 — an important producer of dermacosmetics (intended for the treatment of skin) in the country-came back to attract the interest of national groups, like the Cristália, EMS and Chemical Union, and foreigners, according to sources familiar with the matter.
A businessman who came to look at the business this year reported that the company''s parent, Rose Scaravelli, would have asked for about $ 1 billion by active. "Very expensive. Does not justify the acquisition, "he said. This value is the equivalent of 20 times Ebitda (earnings before interest, taxes, depreciation and amortization) designed the company for this year, according to
the same source. The value would now be around 800,000,000 R$.
The company hired Credit Suisse Bank to sell the asset. Wanted, Rose didn''t want to comment nor confirmed if the company is for sale. Credit Suisse did not want to comment.
The Bank came to present the company to various companies in and out of the country. Last week, there were strong rumors that the company had already been sold.
One of the few threads that still have steady growth in the country, the pharmaceutical industry has lived a strong movement of consolidation between 2009 and 2014, but the assets became
expensive, according to industry sources.
It is expected that sales of medicines this year will grow around 8% of. The demand for generics, which has supported the advancement of the sector has slowed.